Mode
Text Size
Log in / Sign up

Late Wilms tumor recurrence observed 32 years after diagnosis in a single case report.

Late Wilms tumor recurrence observed 32 years after diagnosis in a single case report.
Photo by Markus Spiske / Unsplash
Key Takeaway
Consider extended surveillance for late Wilms tumor recurrence in survivors of favorable-histology disease.

This systematic review examined a single case report involving a one-year-old female patient diagnosed with bilateral, favorable-histology Wilms tumor. The patient underwent a treatment regimen that included chemotherapy, observation with serial imaging, neoadjuvant chemotherapy, left partial nephrectomy, right radical nephrectomy, and adjuvant radiation therapy. The setting and specific institutional details were not reported in the available data.

The primary outcome assessed was the late recurrence of Wilms tumor. The disease-free interval prior to this late recurrence was 32 years after the initial diagnosis. No specific adverse events, serious adverse events, discontinuations, or tolerability data were reported for this single case. The review did not provide p-values, confidence intervals, or absolute numbers beyond the single case description.

Key limitations of this evidence include the small sample size of one case and the lack of a control group or comparator. As an observational case report, causal inferences regarding treatment efficacy or recurrence risk cannot be drawn. The practice relevance highlights the importance of multidisciplinary management in this rare clinical scenario of late recurrence of Wilms tumor. Clinicians should recognize that late recurrences can occur decades after initial treatment, necessitating extended follow-up protocols for survivors of favorable-histology Wilms tumor.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundWilms tumor (WT) is the most common pediatric renal malignancy, but carries a significantly worse prognosis in the adult population. Late recurrence (LR) of a primary WT, defined as disease recurrence five or more years after initial diagnosis, is rare and does not have standardized treatment regimens outside the pediatric population. In this paper we report a LR 32 years after diagnosis, the longest documented disease-free interval ever described.Case presentationA one-year-old female patient was diagnosed with bilateral, favorable-histology WT and treated with chemotherapy. Biopsies of residual masses after treatment confirmed benign tissue, and she was observed with serial imaging for seventeen years without evidence of recurrence. Thirty-two years after initial diagnosis, she presented with gross hematuria and right-sided abdominal pain. Biopsy demonstrated of the left renal mass was consistent with a LR of WT. She received neoadjuvant chemotherapy followed by left partial nephrectomy, right radical nephrectomy, and adjuvant radiation therapy and remains cancer free without any evidence of tumor recurrence.ConclusionThis case of a 32-year treatment-free interval prior to LR is the longest such case in the medical literature. This case highlights the importance of multidisciplinary management in this rare clinical scenario of LR WT.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.